Clashes, Turmoil and Paranoia: Inside Trump’s FDA
FDA gridlock clouds drug approval timelines, pressuring healthcare stocks and ETFs like XLV and IBB.
FDA gridlock clouds drug approval timelines, pressuring healthcare stocks and ETFs like XLV and IBB.
A federal trade court struck down Trump's 10% tariffs, removing import duties and triggering a risk-on surge across equities, commodities, and FX.
A Bitcoin mining company linked to the Trump family reported its second consecutive quarterly loss, raising concerns about profitability in the sector…
Oil and stocks face binary outcomes based on how seriously markets interpret Trump's latest deal-making effort.